
Electromed (ELMD) Stock Forecast & Price Target
Electromed (ELMD) Analyst Ratings
Bulls say
Electromed Inc. demonstrated robust financial growth, with homecare revenue increasing by 14.8% to $14.1 million, driven by enhanced sales representative productivity and strong demand generation. The company has successfully expanded its footprint in the domestic homecare sector while making inroads into acute care and international markets, highlighted by a 41% rise in distributor sales and a remarkable 52% growth in hospital sales. Despite an increase of 17.2% in SG&A expenses due to strategic investments in sales and marketing, these efforts are aligned with Electromed's commitment to fostering long-term growth.
Bears say
Electromed Inc faces significant challenges that contribute to a negative outlook on its stock, including margin compression, which may pressure profitability, and competitive headwinds that threaten market position. Additionally, reduced productivity among the sales force could hinder revenue growth, further exacerbating financial performance issues. Delays in the anticipated contributions from Pain Management and Wound Care segments may also negatively impact overall growth rates and future margins.
This aggregate rating is based on analysts' research of Electromed and is not a guaranteed prediction by Public.com or investment advice.
Electromed (ELMD) Analyst Forecast & Price Prediction
Start investing in Electromed (ELMD)
Order type
Buy in
Order amount
Est. shares
0 shares